Members of the Sackler family who own Purdue Pharma LP have offered roughly US$4.3 billion to resolve sprawling opioid litigation, up from US$3 billion initially proposed in settlement discussions underway in the OxyContin maker’s bankruptcy proceedings, four people familiar with the matter said.
